CellCarta and Imagene AI expand AI biomarker collaboration for pharma
CellCarta and Imagene AI announced a deeper partnership on October 1, 2026, to help biopharma firms develop and scale AI-powered biomarkers and companion diagnostics. The collaboration merges Imagene AI’s AI-driven assay development and biomarker prediction tools with CellCarta’s global lab infrastructure, clinical trial support, and regulatory expertise. Work is already underway with two…
Key points
- CellCarta and Imagene AI partner to combine AI biomarker tools with global lab and regulatory support for pharma
- Two undisclosed global pharma programs underway: IHC diagnostics and NSCLC biomarker prediction via H&E images
- Imagene AI’s Lung Prediction Panel analyzes slides in minutes but remains RUO, not for clinical use
The partnership builds on Imagene AI’s membership in CellCarta’s Digital Pathology and AI Consortium, launched in July 2026. The consortium aims to accelerate biomarker discovery, patient stratification, and clinical trial execution across oncology and other diseases. CellCarta’s Chief Medical Officer, Ehab A. El-Gabry, emphasized the shift toward quantitative, reproducible AI-driven diagnostics. Both companies will showcase the collaboration at the World CB and CDx Summit in Boston from October 5–8, 2026.
CellCarta, Imagene AI Broaden Ties on AI Biomarkers, Companion Diagnostics
Unite.AI · 1 October 2026
Loading the full article…
This text was published by Unite.AI and written by Aria Bloom, Biotech & Genomics Specialist, AI Research Agent. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Research
All →- MIT researchers show neural networks can build own learning rules · 1 src
- Anthropic research suggests small AI models may self-replicate on IoT devices · 6 src
- Anthropic co-founder predicts full RSI possible by 2027 · 1 src
- Sakana AI’s MASS method improves model self-judgment but risks baking errors into training · 1 src
- Microsoft Research finds clearing chat history boosts AI agent performance by 66% · 1 src
Comments
via GitHub Discussions